D-0576-2020 Class II Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

Recall Details

Product Type
Drugs
Report Date
December 18, 2019
Initiation Date
December 2, 2019
Termination Date
October 14, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,824 bottles

Product Description

Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.

Reason for Recall

Presence of Foreign Substance: Presence of a foreign object in a single tablet.

Distribution Pattern

Nationwide in the USA.

Code Information

Lot #: NT119005A, Exp 07/2021